Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa M Howard-McNatt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Breast Cancer (Dove Medical Press)|March 21, 2014
Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefitMarissa M Howard-McNatt
The American Surgeon|November 3, 2021
Evaluation of the Axillary Surgery Performed in Clinically Node-Positive Breast Cancer Patients Following Neoadjuvant ChemotherapyJane B Pearce, Fang-Chi Hsu, Marissa M Howard-McNatt, et al.
Cancers|October 14, 2022
Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast CancerAlaa Bawaneh, Adam S Wilson, Nicole Levi, et al.
Acta Biomaterialia|December 15, 2025
The effect of stiffness on cell behavior and drug resistance in patient-derived breast cancer organoidsWonwoo Jeong, Dongju Kim, Nadeem Wajih, et al.
The American Surgeon|April 15, 2021
Does Localization Technique Matter for Non-palpable Breast Cancers?Anees B Chagpar, Carlos Garcia-Cantu, Marissa M Howard-McNatt, et al.
Annals of Surgical Oncology|August 23, 2025
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|August 29, 2025
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|July 23, 2025
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 TrialMandeep Kaur, Katrina Dimitroff, Judy C Boughey, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Breast Cancer (Dove Medical Press)|March 21, 2014
Patients opting for breast reconstruction following mastectomy: an analysis of uptake rates and benefitMarissa M Howard-McNatt
The American Surgeon|November 3, 2021
Evaluation of the Axillary Surgery Performed in Clinically Node-Positive Breast Cancer Patients Following Neoadjuvant ChemotherapyJane B Pearce, Fang-Chi Hsu, Marissa M Howard-McNatt, et al.
Cancers|October 14, 2022
Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast CancerAlaa Bawaneh, Adam S Wilson, Nicole Levi, et al.
Acta Biomaterialia|December 15, 2025
The effect of stiffness on cell behavior and drug resistance in patient-derived breast cancer organoidsWonwoo Jeong, Dongju Kim, Nadeem Wajih, et al.
The American Surgeon|April 15, 2021
Does Localization Technique Matter for Non-palpable Breast Cancers?Anees B Chagpar, Carlos Garcia-Cantu, Marissa M Howard-McNatt, et al.
Annals of Surgical Oncology|August 23, 2025
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|August 29, 2025
ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical TrialJulie Van Hassel, Katrina Dimitroff, Christina Yau, et al.
Annals of Surgical Oncology|July 23, 2025
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 TrialMandeep Kaur, Katrina Dimitroff, Judy C Boughey, et al.
Pageof 1